Julia H. Rowland and Tom Smith receive NCCS Ellen L. Stovall Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Julia H. Rowland, member of the National Coalition for Cancer Survivorship Board of Directors and former director of NCI’s Office of Cancer Survivorship, and Thomas J. Smith, director of palliative medicine for Johns Hopkins Medicine, received the 2020 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care, presented by The National Coalition for Cancer Survivorship.

Rowland and Smith received the award Nov. 18 at the NCCS virtual awards reception.

The award is named for former NCCS CEO Ellen Stovall, who died in 2016 due to long-term complications from three bouts of cancer.

Rowland is a long-time clinician, researcher, and teacher in the area of psychosocial aspects of cancer. She has worked with and conducted competitively funded research among both pediatric and adult cancer survivors and published broadly in psycho-oncology.

She was recruited to NCI to become the first, full-time director of the Office of Cancer Survivorship. After 18 years in this role, Rowland retired from service at the NCI in September 2017 and assumed the role of senior strategic advisor at Smith Center for Healing and the Arts, a small non-profit organization that provides integrative support services to cancer patients and their families.

Smith is a professor of oncology at the Johns Hopkins University School of Medicine and the Harry J. Duffey Family Professor of Palliative Care.

He is a medical oncologist and a palliative care specialist with a lifelong interest in better symptom management, communication, and improving access to high quality affordable care.

Smith began Johns Hopkins’ hospital-wide palliative care consult service as well as an inpatient unit. He is also a prostate cancer survivor, experiencing first-hand surgery, recurrence, salvage radiation therapy and androgen deprivation therapy with many significant side effects.

Delegate Eleanor Holmes Norton (D-DC) presented the award to her constituent, Julia H. Rowland, and Sen. Chris Van Hollen (D-MD) presented the award to his constituent, Thomas J. Smith.

Table of Contents

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login